Related Experiment Videos

Mutations of the MEN1 tumor suppressor gene in pituitary tumors

Z Zhuang1, S Z Ezzat, A O Vortmeyer

  • 1Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA.

Cancer Research
|January 4, 1998
PubMed

Insights

Genetic alterations in the Multiple Endocrine Neoplasia type 1 (MEN1) gene are implicated in pituitary tumor development. This study found MEN1 gene mutations and deletions in a subset of sporadic pituitary adenomas, suggesting a causative role.

Area of Science:

  • Endocrinology
  • Oncology
  • Genetics

Background:

  • Pituitary adenomas are monoclonal tumors with largely unknown genetic causes.
  • While some arise in Multiple Endocrine Neoplasia type 1 (MEN1) syndrome, sporadic cases lack identified genetic drivers.
  • The MEN1 gene, responsible for MEN1 syndrome, was recently identified.

Purpose of the Study:

  • To investigate the role of the MEN1 gene in the development of sporadic pituitary adenomas.
  • To examine MEN1 gene mutations and allelic deletions in pituitary tumors.

Main Methods:

  • Analysis of MEN1 gene mutations and allelic deletions in 39 sporadic pituitary adenomas and 1 familial MEN1-associated pituitary adenoma.
  • Comparison of tumor DNA with germ-line DNA where available.

Main Results:

  • Four of 39 sporadic pituitary adenomas exhibited MEN1 gene allelic deletions.
  • Two of these sporadic tumors also had specific MEN1 gene mutations in the remaining allele.
  • The familial MEN1 case showed a MEN1 mutation in both tumor and germ-line DNA, with an additional allelic deletion in the tumor.

Conclusions:

  • Genetic alterations of the MEN1 gene are a potential mechanism in pituitary tumorigenesis.
  • Somatic MEN1 gene mutations and deletions contribute to the development of a subset of sporadic pituitary adenomas.

Related Concept Videos